Download PDF
1 / Pages

Other users also viewed these articles

Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5
Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study Laura Cano-García; Sara Manrique-Arija; Rocío Redondo-Rodríguez; Marta Vera-Ruiz; Jose Manuel Lisbona-Montañez; Arkaitz Mucientes-Ruiz; Aimara García-Studer; Fernando Ortiz-Marquez; Natalia Mena-Vázquez; Antonio Fernández-Nebro;
Reumatol Clin. 2024;20:297-304
Ultrasound tenosynovitis: A differential feature of patients with seronegative rheumatoid arthritis Santiago Ruta; Einer Sanchez Prado; Facundo Salvatori; Juan Arguello; Darío Aguerre; Sebastián Magri; Rodrigo García Salinas;
Reumatol Clin. 2023;19:63-6